Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA yield high or low?
The EBITDA yield of 1.34% is in line with its estimated 1-year average of 1.36%, near the low end of its estimated 1-year range (1.30%–1.45%).
As of 2026-10-06T15:56:39.858Z.
Calculation as of: 2026-10-06T15:56:39.858Z.
Quote observation: 2026-10-06T15:54:38.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: a63c12ce7055b0216585e16b4e08b2fd6453147ab6d4be874ec80e726ee32667
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EBITDA YIELD
1.34%
EBITDA YIELD AVG TTM
N/A
EBITDA YIELD AVG 3Y
N/A
EBITDA YIELD AVG 5Y
N/A
EBITDA YIELD AVG 10Y
N/A
EBITDA YIELD AVG 15Y
N/A
EBITDA YIELD AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
6.33%
median of 197 covered companies
CURRENT VS SECTOR MEDIAN
-78.83%
vs the sector median at left
Market Cap
$133.13M
EBITDA Yield
9.61%
TTM Avg
3.05%
3Y Avg
2.67%
5Y Avg
2.31%
Market Cap
$136.15M
EBITDA Yield
0.23%
TTM Avg
0.33%
3Y Avg
3.24%
5Y Avg
2.95%
Market Cap
$136.86M
EBITDA Yield
N/A
TTM Avg
0.23%
3Y Avg
1.76%
5Y Avg
3.40%
| NAME | MARKET CAP | EBITDA YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Health Catalyst, Inc. (HCAT) | $131.53M | 1.34% | N/A | N/A | N/A |
| Organigram Global Inc. (OGI)vs › | $133.13M | 9.61% | 3.05% | 2.67% | 2.31% |
| LifeMD, Inc. (LFMD)vs › | $134.69M | N/A | 4.68% | 4.68% | 4.68% |
| Pyxis Oncology, Inc. (PYXS)vs › | $134.80M | N/A | N/A | N/A | N/A |
| Entera Bio Ltd. (ENTX)vs › | $128.40M | N/A | 27.23% | 27.23% | 27.23% |
| AirSculpt Technologies, Inc. (AIRS)vs › | $136.15M | 0.23% | 0.33% | 3.24% | 2.95% |
| Freenome, Inc. (FRNM)vs › | $136.27M | N/A | N/A | N/A | N/A |
| KORU Medical Systems, Inc. (KRMD)vs › | $136.86M | N/A | 0.23% | 1.76% | 3.40% |
| Atrium Therapeutics, Inc. (RNA)vs › | $137.19M | N/A | N/A | N/A | N/A |
| NRx Pharmaceuticals, Inc. (NRXP)vs › | $124.91M | N/A | 0.18% | 0.16% | 0.16% |
EBITDA Yield = TTM EBITDA / Enterprise Value
EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA YIELD |
|---|---|
| 2026-10-05 | 1.35% |
| 2026-10-02 | 1.35% |
| 2026-10-01 | 1.37% |
| 2026-09-30 | 1.36% |
| 2026-09-29 | 1.35% |
| 2026-09-28 | 1.34% |
| 2026-09-25 | 1.36% |
| 2026-09-24 | 1.36% |
| 2026-09-23 | 1.36% |
| 2026-09-22 | 1.30% |
| 2026-09-21 | 1.33% |
| 2026-09-18 | 1.34% |
| 2026-09-17 | 1.33% |
| 2026-09-16 | 1.36% |
| 2026-09-15 | 1.36% |
| 2026-09-14 | 1.32% |
| 2026-09-11 | 1.37% |
| 2026-09-10 | 1.36% |
| 2026-09-09 | 1.36% |
| 2026-09-08 | 1.37% |
| 2026-09-04 | 1.38% |
| 2026-09-03 | 1.37% |
| 2026-09-02 | 1.38% |
| 2026-09-01 | 1.37% |
| 2026-08-31 | 1.40% |
| 2026-08-28 | 1.42% |
| 2026-08-27 | 1.42% |
| 2026-08-26 | 1.42% |
| 2026-08-25 | 1.43% |
| 2026-08-24 | 1.42% |
| 2026-08-21 | 1.45% |
| 2026-08-20 | 1.40% |
| 2026-08-19 | 1.38% |
| 2026-08-18 | 1.37% |
| 2026-08-17 | 1.37% |
| 2026-08-14 | 1.31% |
| 2026-08-13 | 1.35% |
| 2026-08-12 | 1.34% |
| 2026-08-11 | 1.35% |
| 2026-08-10 | 1.36% |
| 2026-08-07 | 1.36% |
